Skip to content Skip to footer
Close
Literature Reviews

Complete Guide to GenAI-enabled Literature Review for Life Sciences: MadeAi vs. Competitors

Thought Leadership12 February 2026128Views0Likes0Comments
Every professional in the life sciences knows the feeling: literature review is challenging, time-consuming, and above all, exhausting. This essential step in research can feel like a massive hurdle, slowing down innovation and consuming countless hours. Recognizing this frustration, MadeAi developed MadeAi-LR, a powerful GenAI-enabled solution designed to transform the literature review process. It provides the…

Read More

Literature Review

Literature Reviews: How AI is Revolutionizing Systematic Research

Thought Leadership4 February 2026118Views0Likes0Comments
In an era where scientific publications double every nine years and over 2.5 million new research papers are published each year, keeping your literature review up to date is nearly impossible. Enter the Living Literature Review, a significant shift that turns static research snapshots into continually evolving knowledge ecosystems. Why Traditional Literature Reviews Are Becoming…

Read More

FDA Literature Review

FDA Literature Review Requirements: Leveraging AI into Your Literature Review Strategy

Thought Leadership23 January 202656Views0Likes0Comments
Understanding FDA Literature Review Requirements The FDA requires literature reviews to ensure that regulatory decisions are based on solid scientific evidence. This isn't just about compiling papers; it's about systematically searching, appraising, and synthesizing published data to demonstrate safety, efficacy, and compliance. These requirements span multiple domains, from drug approvals to medical devices and health…

Read More

Literature Reviews

A Smarter Way to Adopt AI for Literature Reviews in Regulated Environments

Thought Leadership16 January 202676Views0Likes0Comments
Though many organizations see the value of AI in literature reviews and evidence generation, not all can adopt AI in the same way. Some teams are ready for a web-based SaaS solution. While others, especially large pharma and regulated enterprises, face internal AI policy barriers, data residency requirements, and IT constraints that make SaaS adoption difficult,…

Read More